HOLLAND & KNIGHT LLP lobbying for UNITED MITOCHONDRIAL DISEASE FOUNDATION

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 13, 2025

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

FY 2025 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research); Medical Nutrition Equity Act; Advancing Kids Access to Care Act; Rare Pediatric Disease Voucher Review Program; Telehealth Authority extension.

Budget/Appropriations

FY 2025 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research).